Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients

Area of Science:

• Neuroscience
• Biochemistry
• Genetics

Background:

• Inositol monophosphatase (IMPase) activity is reportedly lower in lymphocyte-derived cell lines from bipolar disorder patients.
• This finding suggests a potential biomarker for bipolar disorder.

Purpose of the Study:

• To replicate the previously reported reduction in IMPase activity in bipolar patients.
• To investigate if this reduction is specific to bipolar disorder compared to other psychiatric conditions.
• To examine IMPase activity in postmortem brain tissue to understand the localization of the enzymatic defect.

Main Methods:

• Spectrophotometric measurement of IMPase activity by quantifying inorganic phosphate released from inositol-1-phosphate.
• Analysis of lymphocyte-derived cell lines from bipolar, unipolar, and schizophrenic patients.
• Analysis of postmortem cortical tissue samples from control and patient groups.

Main Results:

• The reduction in lymphocyte-derived IMPase activity in bipolar patients was successfully replicated.
• No reduction in IMPase activity was observed in cell lines from unipolar or schizophrenic patients.
• IMPase activity in postmortem frontal and occipital cortical samples did not differ between bipolar, unipolar, schizophrenic patients, and controls.

Conclusions:

• The specific reduction of IMPase in lymphocytes but not in cortical tissue suggests a potential genetic basis, possibly linked to the IMPA-2 gene, which is predominantly expressed in leukocytes.
• Lymphocyte IMPase activity may serve as a specific indicator for bipolar disorder, distinct from other major psychiatric disorders.
• The findings highlight the importance of considering tissue-specific gene expression and enzyme activity in understanding the pathophysiology of psychiatric disorders.